For the Inventor, By the Inventor

Enter assignee name

Helmholtz-Gemeinschaft Berlin, Germany

Max-Delbrück-Centrum Für Molekulare Medizin In Der

USPTO Granted Patents = 2

Forward Citations = 0

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Thomas Blankenstein (1 out of 11 patents)

Jonathan Alles (1 out of 6 patents)

Antonio Pezzutto (1 out of 3 patents)

4. Nikolaus Rajewsky (1 out of 2 patents)

5. Nikolaos Karaiskos (1 out of 2 patents)

6. Simone Rhein (1 out of 1 patent)

7. Ivano Legnini (1 out of 1 patent)

8. Salah Ayoub (1 out of 1 patent)

2 patents: Sort by Forward Citations

1. 12421290 - CD22-specific T cell receptors and adoptive T cell therapy for treatment of B cell malignancies (2025-09-23),

2. 12286670 - Full-length RNA sequencing (2025-04-29),

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

2 Patents

#1 in Helmholtz-Gemeinschaft Berlin

#10,556 in Germany

Helmholtz-Gemeinschaft Berlin, Germany

Max-Delbrück-Centrum Für Molekulare Medizin In Der

Forward Citations = 0

8 inventors:

Thomas Blankenstein (1 out of 11 patents)

Jonathan Alles (1 out of 6 patents)

Antonio Pezzutto (1 out of 3 patents)

4. Nikolaus Rajewsky (1 out of 2 patents)

5. Nikolaos Karaiskos (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…